abrdn Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
abrdn Investment Management's AMGN Position: Q2 2017 in Review
abrdn Investment Management reduced its Amgen (AMGN) stake by 84% in Q2 2017, selling an estimated $114M and leaving 137,015 shares worth $23.6M. The position accounts for 0.08% of the portfolio, ranked #144.
abrdn Investment Management first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $427M in Q1 2015. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.
- abrdn Investment Management held 137,015 shares of Amgen worth $23.6M as of Q2 2017.
- abrdn Investment Management sold 700,102 Amgen shares in Q2 2017, an estimated $114M.
- Amgen made up 0.08% of abrdn Investment Management's portfolio in Q2 2017, its #144 holding.
- abrdn Investment Management first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
- abrdn Investment Management's Amgen position peaked at $427M in Q1 2015.
- 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.
Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.